用户名: 密码: 验证码:
Fructus mume extracts alleviate cognitive impairments in 5XFAD transgenic mice
详细信息    查看全文
  • 作者:Jung-Cheol Park ; Jinhua Ma ; Won Kyung Jeon…
  • 关键词:Fructus mume ; Alzheimer’s disease ; Cognition ; Choline acetyltransferase ; 5XFAD
  • 刊名:BMC Complementary and Alternative Medicine
  • 出版年:2016
  • 出版时间:December 2016
  • 年:2016
  • 卷:16
  • 期:1
  • 全文大小:572 KB
  • 参考文献:1.Liu L, Yuan S, Sun Y, Long Y, Li Y, Niu Y, et al. The possible mechanisms of Fructus Mume pill in the treatment of colitis induced by 2,4,6-trinitrobenzene sulfonic acid in rats. J Ethnopharmacol. 2009;126(3):557–64.CrossRef PubMed
    2.Choi HJ, Kang OH, Park PS, Chae HS, Oh YC, Lee YS, et al. Mume Fructus water extract inhibits pro-inflammatory mediators in lipopolysaccharide-stimulated macrophages. J Med Food. 2007;10(3):460–6.CrossRef PubMed
    3.Tomimoto H, Ihara M, Wakita H, Ohtani R, Lin JX, Akiguchi I, et al. Chronic cerebral hypoperfusion induces white matter lesions and loss of oligodendroglia with DNA fragmentation in the rat. Acta Neuropathol. 2003;106(6):527–34.CrossRef PubMed
    4.Tsuchiya M, Sako K, Yura S, Yonemasu Y. Cerebral blood flow and histopathological changes following permanent bilateral carotid artery ligation in Wistar rats. Exp Brain Res. 1992;89(1):87–92.CrossRef PubMed
    5.Wakita H, Tomimoto H, Akiguchi I, Kimura J. Dose-dependent, protective effect of FK506 against white matter changes in the rat brain after chronic cerebral ischemia. Brain Res. 1998;792(1):105–13.CrossRef PubMed
    6.Jeon WK, Ma J, Choi BR, Han SH, Jin Q, Hwang BY, et al. Effects of Fructus mume Extract on MAPK and NF-kappaB Signaling and the Resultant Improvement in the Cognitive Deficits Induced by Chronic Cerebral Hypoperfusion. Evid Based Complement Alternat Med. 2012;2012:450838.PubMedCentral PubMed
    7.Kim MS, Jeon WK, Lee KW, Park YH, Han JS. Ameliorating Effects of Ethanol Extract of Fructus mume on Scopolamine-Induced Memory Impairment in Mice. Evid Based Complement Alternat Med. 2015;2015:102734.PubMedCentral PubMed
    8.Paul S, Jeon WK, Bizon JL, Han JS. Interaction of basal forebrain cholinergic neurons with the glucocorticoid system in stress regulation and cognitive impairment. Front Aging Neurosci. 2015;7:43.PubMedCentral PubMed
    9.Selkoe DJ, Schenk D. Alzheimer’s disease: molecular understanding predicts amyloid-based therapeutics. Annu Rev Pharmacol Toxicol. 2003;43:545–84.CrossRef PubMed
    10.Park GA, Pappas BA, Murtha SM, Ally A. Enriched environment primes forebrain choline acetyltransferase activity to respond to learning experience. Neurosci Lett. 1992;143(1-2):259–62.CrossRef PubMed
    11.Lippa AS, Pelham RW, Beer B, Critchett DJ, Dean RL, Bartus RT. Brain cholinergic dysfunction and memory in aged rats. Neurobiol Aging. 1980;1(1):13–9.CrossRef PubMed
    12.Dickinson-Anson H, Aubert I, Gage FH, Fisher LJ. Hippocampal grafts of acetylcholine-producing cells are sufficient to improve behavioural performance following a unilateral fimbria-fornix lesion. Neuroscience. 1998;84(3):771–81.CrossRef PubMed
    13.Choi BR, Kwon KJ, Park SH, Jeon WK, Han SH, Kim HY, et al. Alternations of Septal-hippocampal System in the Adult Wistar Rat with Spatial Memory Impairments Induced by Chronic Cerebral Hypoperfusion. Exp Neurobiol. 2011;20(2):92–9.PubMedCentral CrossRef PubMed
    14.Kumaran D, Udayabanu M, Kumar M, Aneja R, Katyal A. Involvement of angiotensin converting enzyme in cerebral hypoperfusion induced anterograde memory impairment and cholinergic dysfunction in rats. Neuroscience. 2008;155(3):626–39.CrossRef PubMed
    15.Contestabile A, Ciani E. The place of choline acetyltransferase activity measurement in the “cholinergic hypothesis” of neurodegenerative diseases. Neurochem Res. 2008;33(2):318–27.CrossRef PubMed
    16.Christensen DZ, Bayer TA, Wirths O. Intracellular Ass triggers neuron loss in the cholinergic system of the APP/PS1KI mouse model of Alzheimer’s disease. Neurobiol Aging. 2010;31(7):1153–63.CrossRef PubMed
    17.Boncristiano S, Calhoun ME, Kelly PH, Pfeifer M, Bondolfi L, Stalder M, et al. Cholinergic changes in the APP23 transgenic mouse model of cerebral amyloidosis. J Neurosci. 2002;22(8):3234–43.PubMed
    18.Oakley H, Cole SL, Logan S, Maus E, Shao P, Craft J, et al. Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer’s disease mutations: potential factors in amyloid plaque formation. J Neurosci. 2006;26(40):10129–40.CrossRef PubMed
    19.Kimura R, Ohno M. Impairments in remote memory stabilization precede hippocampal synaptic and cognitive failures in 5XFAD Alzheimer mouse model. Neurobiol Dis. 2009;33(2):229–35.PubMedCentral CrossRef PubMed
    20.Ohno M. Failures to reconsolidate memory in a mouse model of Alzheimer’s disease. Neurobiol Learn Mem. 2009;92(3):455–9.PubMedCentral CrossRef PubMed
    21.Devi L, Ohno M. Phospho-eIF2alpha level is important for determining abilities of BACE1 reduction to rescue cholinergic neurodegeneration and memory defects in 5XFAD mice. PLoS One. 2010;5(9):e12974.PubMedCentral CrossRef PubMed
    22.Jin Q, Lee C, Lee JW, Lee IS, Lee MK, Jeon WK, et al. Chemical Constituents from the Fruits of Prunus mume. Nat Prod Sci. 2012;18(3):200–3.
    23.Kanno T, Tsuchiya A, Nishizaki T. Hyperphosphorylation of Tau at Ser396 occurs in the much earlier stage than appearance of learning and memory disorders in 5XFAD mice. Behav Brain Res. 2014;274C:302–6.CrossRef
    24.Save E, Poucet B, Foreman N, Buhot MC. Object exploration and reactions to spatial and nonspatial changes in hooded rats following damage to parietal cortex or hippocampal formation. Behav Neurosci. 1992;106(3):447–56.CrossRef PubMed
    25.Devi L, Ohno M. PERK mediates eIF2alpha phosphorylation responsible for BACE1 elevation, CREB dysfunction and neurodegeneration in a mouse model of Alzheimer’s disease. Neurobiol Aging. 2014;35(10):2272–81.PubMedCentral CrossRef PubMed
    26.Lee KM, Bang J, Kim BY, Lee IS, Han JS, Hwang BY, et al. Fructus mume alleviates chronic cerebral hypoperfusion-induced white matter and hippocampal damage via inhibition of inflammation and downregulation of TLR4 and p38 MAPK signaling. BMC Complement Altern Med. 2015;15(1):125.PubMedCentral CrossRef PubMed
    27.Ikonomovic MD, Mufson EJ, Wuu J, Cochran EJ, Bennett DA, DeKosky ST. Cholinergic plasticity in hippocampus of individuals with mild cognitive impairment: correlation with Alzheimer’s neuropathology. J Alzheimers Dis. 2003;5(1):39–48.PubMed
    28.Iversen SD. Behavioural evaluation of cholinergic drugs. Life Sci. 1997;60(13-14):1145–52.CrossRef PubMed
    29.Tarricone BJ, Simon JR, Li YJ, Low WC. Neural grafting of cholinergic neurons in the hippocampal formation. Behav Brain Res. 1996;74(1-2):25–44.CrossRef PubMed
    30.Cassel JC, Duconseille E, Jeltsch H, Will B. The fimbria-fornix/cingular bundle pathways: a review of neurochemical and behavioural approaches using lesions and transplantation techniques. Prog Neurobiol. 1997;51(6):663–716.CrossRef PubMed
    31.Cassel JC, Gaurivaud M, Lazarus C, Bertrand F, Galani R, Jeltsch H. Grafts of fetal septal cells after cholinergic immunotoxic denervation of the hippocampus: a functional dissociation between dorsal and ventral implantation sites. Neuroscience. 2002;113(4):871–82.CrossRef PubMed
    32.Sberna G, Saez-Valero J, Li QX, Czech C, Beyreuther K, Masters CL, et al. Acetylcholinesterase is increased in the brains of transgenic mice expressing the C-terminal fragment (CT100) of the beta-amyloid protein precursor of Alzheimer’s disease. J Neurochem. 1998;71(2):723–31.CrossRef PubMed
    33.Sberna G, Saez-Valero J, Beyreuther K, Masters CL, Small DH. The amyloid beta-protein of Alzheimer’s disease increases acetylcholinesterase expression by increasing intracellular calcium in embryonal carcinoma P19 cells. J Neurochem. 1997;69(3):1177–84.CrossRef PubMed
    34.Hu W, Gray NW, Brimijoin S. Amyloid-beta increases acetylcholinesterase expression in neuroblastoma cells by reducing enzyme degradation. J Neurochem. 2003;86(2):470–8.CrossRef PubMed
    35.Carroll RT, Lust MR, Emmerling MR. Beta-amyloid levels predict cholinesterase activity in human cerebrospinal fluid. Neuroreport. 1999;10(1):127–30.CrossRef PubMed
    36.Rees T, Hammond PI, Soreq H, Younkin S, Brimijoin S. Acetylcholinesterase promotes beta-amyloid plaques in cerebral cortex. Neurobiol Aging. 2003;24(6):777–87.CrossRef PubMed
    37.Dong H, Csernansky CA, Martin MV, Bertchume A, Vallera D, Csernansky JG. Acetylcholinesterase inhibitors ameliorate behavioral deficits in the Tg2576 mouse model of Alzheimer’s disease. Psychopharmacology (Berl). 2005;181(1):145–52.CrossRef
    38.Cho WH, Park JC, Chung C, Jeon WK, Han JS. Learning strategy preference of 5XFAD transgenic mice depends on the sequence of place/spatial and cued training in the water maze task. Behav Brain Res. 2014;273:116–22.CrossRef PubMed
    39.Glass CK, Saijo K, Winner B, Marchetto MC, Gage FH. Mechanisms underlying inflammation in neurodegeneration. Cell. 2010;140(6):918–34.PubMedCentral CrossRef PubMed
    40.Morales I, Guzman-Martinez L, Cerda-Troncoso C, Farias GA, Maccioni RB. Neuroinflammation in the pathogenesis of Alzheimer’s disease. A rational framework for the search of novel therapeutic approaches. Front Cell Neurosci. 2014;8:112.PubMedCentral PubMed
  • 作者单位:Jung-Cheol Park (1)
    Jinhua Ma (1)
    Won Kyung Jeon (2)
    Jung-Soo Han (1)

    1. Department of Biological Sciences, Konkuk University, 1 Hwayang-dong, Gwangjin-gu, Seoul, 143-701, Republic of Korea
    2. Herbal Medicine Research Division, Korea Institute of Oriental Medicine, Daejeon, 305-811, Republic of Korea
  • 刊物主题:Complementary & Alternative Medicine; Internal Medicine; Chiropractic Medicine;
  • 出版者:BioMed Central
  • ISSN:1472-6882
文摘
Background Fructus mume (F. mume) has been used as a traditional treatment for ulcer, cough, and digestive problems for many years in Asian countries. Previous studies have demonstrated that F. mume extracts alleviate cognitive deficits in rats with chronic cerebral hypoperfusion and in mice with scopolamine treatments. The present experiment was conducted to examine the effects of F. mume on cognitive impairments in 5XFAD transgenic mice with five familial Alzheimer’s disease (AD) mutations.

© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号

地址:北京市海淀区学院路29号 邮编:100083

电话:办公室:(+86 10)66554848;文献借阅、咨询服务、科技查新:66554700